A microfluidic assay that quantifies the abundance and degree of proliferation of migratory cells predicts the metastatic potential of breast-cancer cell lines and patient-derived cells.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A role for microfluidic systems in precision medicine
Nature Communications Open Access 02 June 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$99.00 per year
only $8.25 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
23 July 2019
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
References
Siegel, R. L., Miller, K. D. & Jemal, A. CA Cancer J. Clin. 69, 7–34 (2019).
Nguyen, D. X., Bos, P. D. & Massague, J. Nat. Rev. Cancer 9, 274–284 (2009).
Bettegowda, C. et al. Sci. Transl. Med. 6, 224ra224 (2014).
Yankaskas, C. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-019-0400-9 (2019).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wan, Z., Kamm, R.D. Microfluidic assessment of metastatic potential. Nat Biomed Eng 3, 423–424 (2019). https://doi.org/10.1038/s41551-019-0412-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41551-019-0412-5
This article is cited by
-
A role for microfluidic systems in precision medicine
Nature Communications (2022)